Net Cash Provided by (Used in) Operating Activities |
-1.72M |
USD |
-79% |
Q1 2025 |
Q1 2025 |
Net Cash Provided by (Used in) Financing Activities |
916K |
USD |
|
Q1 2025 |
Q1 2025 |
Net Cash Provided by (Used in) Investing Activities |
0 |
USD |
|
Q1 2024 |
Q1 2024 |
Common Stock, Shares Authorized |
800M |
shares |
0% |
Q2 2025 |
Q2 2025 |
Common Stock, Shares, Issued |
117M |
shares |
+12.3% |
Q2 2025 |
Q2 2025 |
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect |
-1.54M |
USD |
-121% |
Q1 2023 |
Q1 2023 |
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
1.28M |
USD |
-27.1% |
Q4 2024 |
Q2 2025 |
Interest Paid, Excluding Capitalized Interest, Operating Activities |
66K |
USD |
|
Q1 2025 |
Q1 2025 |
Deferred Tax Assets, Valuation Allowance |
19.6M |
USD |
+13.9% |
Q4 2024 |
FY 2024 |
Deferred Tax Assets, Gross |
19.6M |
USD |
+13.9% |
Q4 2024 |
FY 2024 |
Depreciation |
13K |
USD |
-13.3% |
Q1 2025 |
Q1 2025 |
Payments to Acquire Property, Plant, and Equipment |
0 |
USD |
-100% |
Q1 2024 |
Q1 2024 |
Comprehensive Income (Loss), Net of Tax, Attributable to Parent |
-5.37M |
USD |
-2.21% |
Q2 2025 |
Q2 2025 |
Property, Plant and Equipment, Gross |
526K |
USD |
|
Q2 2025 |
Q2 2025 |
Deferred Tax Assets, Operating Loss Carryforwards |
19M |
USD |
+12.4% |
Q4 2024 |
FY 2024 |
Depreciation, Depletion and Amortization |
15K |
USD |
+66.7% |
Q1 2024 |
Q1 2024 |
Deferred Tax Assets, Net of Valuation Allowance |
0 |
USD |
|
Q4 2023 |
FY 2023 |
Share-based Payment Arrangement, Expense |
746K |
USD |
-3.49% |
Q2 2025 |
Q2 2025 |
Interest Expense |
10K |
USD |
|
Q3 2024 |
Q3 2024 |